Jon Hamilton
Stories
-
NIH announces plan to include private health records in study into autism rates
The NIH has announced an initiative that will use both public and private data from sources including pharmacies and federal health programs to study autism.
-
Two small studies show how stem cells could help treat Parkinson's
Two new studies suggest that stem cells are close to helping people with Parkinson's disease. The results are a victory for scientists who have spent decades trying to treat it with brain cells.
-
Two small studies show how stem cells could help treat Parkinson's
Two new studies suggest that stem cells are close to helping people with Parkinson's disease. The results are a victory for scientists who have spent decades trying to treat it with brain cells.
-
Pain pathway in a dish could aid search for new analgesic drugs
Scientists have recreated a pathway that senses pain, using clusters of human nerve cells grown in a dish.
-
Scientists recreate a pathway that senses pain, using nerve cells grown in a dish
Scientists created a model of the human pain pathway in a dish by connecting four separate brain organoids. The feat should help them understand sensory disorders like those affecting pain perception.
-
Latest Alzheimer's lab tests focus on memory loss, not brain plaques
New tests of blood and spinal fluid can identify people experiencing memory loss from Alzheimer's disease.
-
Predicting cognitive decline in Alzheimer's
New tests of blood and spinal fluid can show how far Alzheimer's has progressed and how fast a patient's memory will decline.
-
Scientists are engineering a sense of touch for people who are paralyzed
Scientists have added a sense of touch to a brain interface. This is key to making simple tasks possible for those who are paralyzed by stroke or spinal injuries.
-
A woman says effects from Alzheimer's have plateaued with new drug Kisunla
Drugs can't stop Alzheimer's disease but sometimes, they can slow it down. This was one woman's experience taking the drug Kisunla.
-
Did an Alzheimer's drug give Sue and Ken Bell more time? Maybe
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.
